Thursday, July 11, 2019 Adjuvant Boosts Venom Immunotherapy for Bee Sting Allergies While venom immunotherapy can be effective for people allergic to honeybee stings, the therapy requires frequent clinic visits and relies on costly venom extracts. A study published in the Journal of Allergy & Clinical Immunology suggests that an NIH-developed adjuvant boosted the effect of immunotherapy in 27 adults—a change that may mitigate some treatment challenges. Read the full paper below from researchers at the University of Adelaide and Flinders University. Photo credit: U.S. Department of Agriculture's Agricultural Research Service National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107